Relx Plc (NYSE:RELX) Shares Purchased by Two Sigma Investments LP

Two Sigma Investments LP raised its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 88.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,318 shares of the technology company's stock after buying an additional 35,445 shares during the period. Two Sigma Investments LP's holdings in Relx were worth $3,421,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. CENTRAL TRUST Co grew its stake in Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Transce3nd LLC bought a new position in Relx in the fourth quarter worth approximately $40,000. Sierra Ocean LLC bought a new position in Relx in the fourth quarter worth approximately $43,000. Brown Brothers Harriman & Co. grew its stake in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Finally, Private Trust Co. NA grew its stake in Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after purchasing an additional 199 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company's stock.

Relx Stock Performance

Shares of NYSE RELX traded down $0.51 during mid-day trading on Tuesday, hitting $54.07. The stock had a trading volume of 1,029,668 shares, compared to its average volume of 722,322. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a 50 day moving average of $52.45 and a two-hundred day moving average of $49.57. Relx Plc has a twelve month low of $43.45 and a twelve month high of $56.33. The firm has a market cap of $99.80 billion, a PE ratio of 29.07, a PEG ratio of 2.73 and a beta of 0.86.

Analysts Set New Price Targets

RELX has been the subject of a number of analyst reports. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Morgan Stanley restated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They set a "buy" rating for the company. Finally, Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.